(Q35584883)

9 August 2017

1 reference

title

Present status of antileishmanial vaccines (English)

1 reference

9 August 2017

1 reference

10.1023/A:1026047429604

https://api.crossref.org/works/10.1023/A:1026047429604

2 April 2024

author name string

Monidipa Ghosh

series ordinal

1

1 reference

9 August 2017

Santu Bandyopadhyay

series ordinal

2

1 reference

9 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14619970

2 April 2024

publication date

1 November 2003

1 reference

Molecular and Cellular Biochemistry

9 August 2017

published in

1 reference

9 August 2017

volume

253

1 reference

9 August 2017

issue

1-2

1 reference

9 August 2017

page(s)

199-205

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1026047429604

9 August 2017

exact match

0 references

cites work

Dendritic cells: specialized and regulated antigen processing machines

1 reference

12 December 2020

Cytokine-producing T cell subsets in human leishmaniasis

1 reference

12 December 2020

The development of a Th1-type response and resistance to Leishmania major infection in the absence of CD40-CD40L costimulation

1 reference

12 December 2020

Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection

1 reference

12 December 2020

Dendritic cells genetically modified to express CD40 ligand and pulsed with antigen can initiate antigen-specific humoral immunity independent of CD4+ T cells

1 reference

12 December 2020

Control of Leishmania major infection in mice lacking TNF receptors.

1 reference

12 December 2020

Mice defective in Fas are highly susceptible to Leishmania major infection despite elevated IL-12 synthesis, strong Th1 responses, and enhanced nitric oxide production.

1 reference

12 December 2020

Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity

1 reference

12 December 2020

N-terminal fatty acid substitution increases the leishmanicidal activity of CA(1-7)M(2-9), a cecropin-melittin hybrid peptide

1 reference

12 December 2020

Development of a safe live Leishmania vaccine line by gene replacement.

1 reference

12 December 2020

BCG Expressing LCR1 of Leishmania chagasi Induces Protective Immunity in Susceptible Mice

1 reference

12 December 2020

Vaccination of vervet monkeys against cutaneous leishmaniosis using recombinant Leishmania 'major surface glycoprotein' (gp63).

1 reference

12 December 2020

Vaccine development against cutaneous leishmaniasis. Subcutaneous administration of radioattenuated parasites protects CBA mice against virulent Leishmania major challenge

1 reference

12 December 2020

Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial

1 reference

12 December 2020

Roles of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis

1 reference

12 December 2020

CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection

1 reference

12 December 2020

The Leishmania promastigote surface antigen-2 (PSA-2) is specifically recognised by Th1 cells in humans with naturally acquired immunity to L. major

1 reference

12 December 2020

Identification and characterisation of a functional peroxidoxin from Leishmania major

1 reference

12 December 2020

Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A.

1 reference

12 December 2020

Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.

1 reference

12 December 2020

Murine dendritic cells pulsed in vitro with Toxoplasma gondii antigens induce protective immunity in vivo

1 reference

12 December 2020

Borrelia burgdorferi-pulsed dendritic cells induce a protective immune response against tick-transmitted spirochetes

1 reference

12 December 2020

Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae

1 reference

12 December 2020

A dhfr-ts- Leishmania major knockout mutant cross-protects against Leishmania amazonensis.

1 reference

12 December 2020

A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing

1 reference

12 December 2020

IFN-beta differentially regulates CD40-induced cytokine secretion by human dendritic cells

1 reference

12 December 2020

Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response

1 reference

12 December 2020

A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran

1 reference

12 December 2020

The multiplex function of nitric oxide in (auto)immunity

1 reference

12 December 2020

Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes

1 reference

12 December 2020

Skin dendritic cells in murine cutaneous leishmaniasis.

1 reference

12 December 2020

The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen

1 reference

12 December 2020

LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.

1 reference

12 December 2020

Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis

1 reference

12 December 2020

Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis

1 reference

12 December 2020

A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major

1 reference

12 December 2020

Immunization through dermal delivery of protein-encoding DNA: a role for migratory dendritic cells

1 reference

12 December 2020

The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge.

1 reference

12 December 2020

Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response

1 reference

12 December 2020

Nitric oxide synthase induces macrophage death by apoptosis

1 reference

12 December 2020

Long-term protection of mice against Leishmania major with a synthetic peptide vaccine

1 reference

12 December 2020

Immunization with Leishmania receptor for macrophages protects mice against cutaneous leishmaniasis

1 reference

12 December 2020

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

1 reference

12 December 2020

Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against American tegumentary leishmaniasis

1 reference

12 December 2020

Dendritic cells and the control of immunity

1 reference

12 December 2020

Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism

1 reference

12 December 2020

Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis

1 reference

12 December 2020

Attenuated Toxoplasma gondii ts-4 mutants engineered to express the Leishmania antigen KMP-11 elicit a specific immune response in BALB/c mice

1 reference

12 December 2020

Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism

1 reference

12 December 2020

Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major

1 reference

12 December 2020

Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection

1 reference

12 December 2020

Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major

1 reference

12 December 2020

Pretreatment with recombinant Flt3 ligand partially protects against progressive cutaneous leishmaniasis in susceptible BALB/c mice

1 reference

12 December 2020

Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leishmania major

1 reference

12 December 2020

Intracellular infection by Leishmania donovani inhibits macrophage apoptosis

1 reference

12 December 2020

Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile

1 reference

12 December 2020

Rapid early onset lymphocyte cell death in mice resistant, but not susceptible to Leishmania major infection

1 reference

12 December 2020

Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1026047429604

1 reference

Dimensions Publication ID

9 August 2017

1020001479

0 references

1 reference